Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2010
12/09/2010US20100311761 Perhydroquinoxaline derivatives
12/09/2010US20100311760 Heterocyclic antiviral compounds
12/09/2010US20100311759 Antiparasitic agent for fish and method of controlling proliferation of fish parasites
12/09/2010US20100311758 Method for diagnosis of inflammatory diseases using calgranulin c
12/09/2010US20100311757 Salarins And Tulearins, Compositions And Uses Thereof
12/09/2010US20100311756 Methods for delaying the progression of at least one of cardiac hypertrophy, cardiac remodeling or left ventricular function or the onset of heart failure in subjects in need of treatment thereof
12/09/2010US20100311755 1,2,4,-triazin-3,5-dione compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
12/09/2010US20100311754 1,4-Disubstituted Naphthalenes as Inhibitors of P38 Map Kinase
12/09/2010US20100311753 C5aR ANTAGONISTS
12/09/2010US20100311752 Substituted pyridazine derivatives
12/09/2010US20100311751 Solid dispersions containing an apoptosis-promoting agent
12/09/2010US20100311750 Organic compounds
12/09/2010US20100311749 4-benzoyl-1-substituted-piperazin-2-one derivatives as p2x7 modulators
12/09/2010US20100311748 Heterocyclic amides useful for the treatment of cancer and psoriasis
12/09/2010US20100311747 Dicycloazaalkane derivates, preparation processes and medical uses thereof
12/09/2010US20100311746 Modulators of muscarinic receptors
12/09/2010US20100311745 1,3-dihydroisoindole derivatives
12/09/2010US20100311744 Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40
12/09/2010US20100311743 Azaindoles Useful as Inhibitors of Janus Kinases
12/09/2010US20100311742 Tyrosine kinase inhibitors as anti-kinetolastid and anti-apicomplexan agents
12/09/2010US20100311741 Bicyclosulfonyl Acid (BCSA) Compounds and Their Use as Therapeutic Agents
12/09/2010US20100311740 Imidazopyridine derivatives as acid pump antagonists
12/09/2010US20100311739 Naphthalene Diimide Compounds
12/09/2010US20100311738 Pharmaceutical Composition For The Parenteral Administration Of Ultrashort-Effective Beta-Adrenoreceptor Antagonists
12/09/2010US20100311737 Pyrimido [4,5-b] -oxazines for use as dgat inhibitors
12/09/2010US20100311736 Pyridosulfonamide derivatives as p13 kinase inhibitors
12/09/2010US20100311735 Inhibitors of human immunodeficiency virus replication
12/09/2010US20100311734 Spiro Compounds Useful as Antagonists of the H1 Receptor
12/09/2010US20100311733 Thiadiazinone derivatives
12/09/2010US20100311732 Novel heterocyclic compounds
12/09/2010US20100311731 Fluoroquinolone Carboxylic Acid Molecular Crystals
12/09/2010US20100311730 Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine Compounds and Their Use
12/09/2010US20100311729 Substituted imidazopyridazines and pyrrolopyrimidines as lipid kinase inhibitors
12/09/2010US20100311728 Manipulation of brain CDP-diacylglycerol and uses thereof
12/09/2010US20100311727 Therapeutic amine-arylsulfonamide conjugate compounds
12/09/2010US20100311726 Reduction of beta-amyloid levels by treatment with the small molecule differentiation-inducing factor
12/09/2010US20100311725 Noribogaine in the treatment of pain and drug addiction
12/09/2010US20100311724 Noribogaine in the treatment of pain and drug addiction
12/09/2010US20100311723 Noribogaine in the treatment of pain and drug addiction
12/09/2010US20100311722 Noribogaine in the treatment of pain and drug addiction
12/09/2010US20100311721 Compounds
12/09/2010US20100311720 Spiroindoline Modulators of Muscarinic Receptors
12/09/2010US20100311719 Prevention of Obesity in Antipsychotic, Antidepressant and Antiepileptic Medication
12/09/2010US20100311718 Treatment of Psychoses with Dibenzothiazepine Antipsychotic
12/09/2010US20100311717 Methods and compositions for retarding weight gain associated with use of atypical antipsychotic drugs
12/09/2010US20100311716 Use of inhibitors of jun n-terminal kinases to treat glaucoma
12/09/2010US20100311715 Alpha carbolines and uses thereof
12/09/2010US20100311714 1H-IMIDAZO[4,5-c]QUINOLINONE COMPOUNDS
12/09/2010US20100311713 Novel Azetidine Compounds Useful in the Treatment of Functional Gastrointestinal Disorders, Ibs and Functional Dyspepsia
12/09/2010US20100311712 Modulators of cxcr7
12/09/2010US20100311711 Inhibitors of NAAA and Methods Thereof
12/09/2010US20100311710 Cyclobutanemethanamine inhibitors of monoamine reuptake
12/09/2010US20100311709 2-[1-PHENYL-5-HYDROXY OR METHOXY-4ALPHA-METHYL-HEXAHYDROCYCLOPENTA [f]INDAZOLE-5-YL]ETHYL PHENYL DERIVATIVES AS GLUCOCORTICOID RECEPTOR LIGANDS
12/09/2010US20100311708 Use of nor-bile acids in the treatment of arteriosclerosis
12/09/2010US20100311707 Controlled release delivery system for nasal applications and methods of treatment
12/09/2010US20100311706 Method of treatment of allergic rhinitis
12/09/2010US20100311705 Ophthalmologic irrigation solutions and method
12/09/2010US20100311704 Pharmaceutical delivery systems for treatment of substance abuse and other addictions
12/09/2010US20100311703 New compounds as adenosine a1 receptor antagonists
12/09/2010US20100311702 19-nor-steroid derivatives with a 15alpha, 16alpha-methylene group and a saturated 17, 17-spiro-lactone ring, use thereof, and medicaments containing said derivatives
12/09/2010US20100311701 Pharmaceutical Co-Crystal Compositions
12/09/2010US20100311700 Transdermal preparation for external use containing nonsterioidal antiinflammatory/analgesic agent
12/09/2010US20100311699 Novel carboxylic acid 4-phenylazo-phenyl ester derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
12/09/2010US20100311698 Aqueous based pharmaceutical formulations of water-soluable prodrugs of propofol
12/09/2010US20100311697 Methods and Compositions for the Treatment of CNS-Related Conditions
12/09/2010US20100311696 Topical skin treatment composition
12/09/2010US20100311695 Hydroxy-bisphosphonic acid derivatives as vector targeting bone tissue
12/09/2010US20100311694 Set of Geldanamycin Derivatives and Their Preparation Methods
12/09/2010US20100311693 Preparation and Uses of 1,2,4-Triazolo [1,5a] Pyridine Derivatives
12/09/2010US20100311692 Pharmaceutical Formulation Containing Choline Alfoscerate
12/09/2010US20100311691 Compositions of s-alkylisothiouronium derivatives for treating upper respiratory congestion
12/09/2010US20100311690 Boropeptide inhibitors of enteropeptidase and their uses in treatment of obesity, overweight and/or diseases associated with an abnormal fat metabolism
12/09/2010US20100311689 Combination therapy with organic arsenicals
12/09/2010US20100311688 Ophthalmic formulations, methods of manufacture, and methods of using same
12/09/2010US20100311687 Polysaccharides derivatised with citric acid
12/09/2010US20100311686 Nutraceutical composition and methods for preventing or treating multiple sclerosis
12/09/2010US20100311684 Novel tricyclic nucleosides or nucleotides as therapeutic agents
12/09/2010US20100311683 Cytidine analogs for treatment of myelodysplastic syndromes
12/09/2010US20100311682 Antimelancholic medicine prepared with jujube camp materials
12/09/2010US20100311681 Stable 6-methoxy-2',3'-dideoxyguanosine, method for preparing the same and pharmaceutical composition containing the same
12/09/2010US20100311680 Synthesis of novel neamine derivatives and use thereof as antibacterial agents
12/09/2010US20100311679 Anticancer treatment with a combination of taxanes and 13-deoxyanthracyclines
12/09/2010US20100311678 Methods and compositions for treating cancer and modulating signal transduction and metabolism pathways
12/09/2010US20100311676 Compositions containing sesamin-class compound(s) and quercetin glycoside(s)
12/09/2010US20100311675 Novel method for preparing purified extracts of harpagophytum procumbens
12/09/2010US20100311674 Pharmaceutical compositions with a mechanism of multi-target receptor retroaction for treating depression
12/09/2010US20100311673 Sulfanyl-tetrahydropyran-based compounds and methods of their use
12/09/2010US20100311670 Conjugates of hydroxyalkyl starch and a protein, prepared by native chemical ligation
12/09/2010US20100311666 Cosmetic use of a protein belonging to the ribonuclease family
12/09/2010US20100311665 Method and Composition for Potentiating an Opiate Analgesic
12/09/2010US20100311663 Memory influencing protein
12/09/2010US20100311662 Treatment of Acute Coronary Syndrome with an Exendin
12/09/2010US20100311661 Use of compounds derived from cycloheximide for the treatment or prevention of, in particular, ischaemias and cardiopathies
12/09/2010US20100311654 Modified Polysaccharide-Based Delivery of Nucleic Acids
12/09/2010US20100311653 Splice variants of gdnf and uses thereof
12/09/2010US20100311649 Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators
12/09/2010US20100311642 Use of v2 receptor antagonists in combination with vaso pressinergic agnosts
12/09/2010US20100311639 Inhibitors of ncca-atp channels for therapy
12/09/2010US20100311638 Method for Altering the Shape of Polymer Particles
12/09/2010US20100311595 Lipophilic drug delivery vehicle and methods of use thereof
1 ... 1965 1966 1967 1968 1969 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 ... 7860